WallStreetZenWallStreetZen

NASDAQ: SLNO
Soleno Therapeutics Inc Stock Ownership - Who owns Soleno Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Soleno Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Patricia C. HiranoOfficer title Senior Vice President Regulatory Affairs2025-04-013,782$70.11
$265.16kSell
Vivo Opportunity LLC10% Owner2025-03-28333,557$70.60
$23.55MSell
Matthew PaulsDirector2025-03-285,937$71.55
$424.80kSell
Matthew PaulsDirector2025-03-285,937$4.60
$27.31kBuy
Patricia C. HiranoOfficer title Senior Vice President Regulatory Affairs2025-03-282,691$73.60
$198.06kSell
Patricia C. HiranoOfficer title Senior Vice President Regulatory Affairs2025-03-289,253$69.52
$643.25kSell
Patricia C. HiranoOfficer title Senior Vice President Regulatory Affairs2025-03-2812,324$68.92
$849.38kSell
Patricia C. HiranoOfficer title Senior Vice President Regulatory Affairs2025-03-282,691$33.60
$90.42kBuy
Patricia C. HiranoOfficer title Senior Vice President Regulatory Affairs2025-03-283,394$67.46
$228.95kSell
Meredith ManningChief Commercial Officer2025-03-2737,000$67.04
$2.48MSell

1 of 17

SLNO insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when SLNO insiders and whales buy or sell their stock.

SLNO Shareholders

What type of owners hold Soleno Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Andrew Sinclair61.78%28,331,704$1.99BInsider
Abingworth LLP54.50%24,991,874$1.76BInsider
Edgar Engleman49.62%22,756,018$1.60BInsider
James Walter Glasheen18.47%8,470,180$595.03MInsider
Stuart J. Collinson15.82%7,252,746$509.51MInsider
Forward V Associates LLC15.64%7,173,976$503.97MInsider
Vivo Capital LLC13.72%6,291,851$442.00MInstitution
Janus Henderson Group PLC11.31%5,188,265$364.48MInstitution
Perceptive Advisors LLC10.94%5,018,997$352.58MInsider
Vivo Opportunity LLC9.72%4,458,294$313.20MInsider

1 of 3

SLNO vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
SLNO30.26%69.74%Net SellingNet Selling
RARE84.55%15.45%Net SellingNet Selling
CRSP65.93%34.07%Net SellingNet Selling
ZLAB5.21%1.75%Net SellingNet Selling
RNA88.46%11.54%Net SellingNet Selling
View Top Biotech Stocks

Soleno Therapeutics Stock Ownership FAQ

Who owns Soleno Therapeutics?

Soleno Therapeutics (NASDAQ: SLNO) is owned by 111.30% institutional shareholders, 256.51% Soleno Therapeutics insiders, and 0.00% retail investors. Andrew Sinclair is the largest individual Soleno Therapeutics shareholder, owning 28.33M shares representing 61.78% of the company. Andrew Sinclair's Soleno Therapeutics shares are currently valued at $1.98B.

If you're new to stock investing, here's how to buy Soleno Therapeutics stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.